<DOC>
	<DOCNO>NCT00528320</DOCNO>
	<brief_summary>This study provide continued access registry cardiac resynchronization therapy defibrillation ( CRT-D ) , help resynchronize ( coordinate ) rhythm heart help leave ventricle contract ( pump blood ) uniformly , patient severe heart failure ( New York Heart Association [ NYHA ] Class III IV ) . Quality life , adverse event device success analyze report .</brief_summary>
	<brief_title>Clinical Evaluation Cardiac Resynchronization Therapy ( CRT ) Using Ovatio CRT Implantable Cardioverter-defibrillator ( ICD ) System</brief_title>
	<detailed_description>ICDs show increase life expectancy substantially various drug regimens patient life threaten ventricular arrhythmia . Furthermore , large scale study cardiac resynchronization therapy ICD-indicated heart failure patient demonstrate improvement functional capacity quality life , without unacceptable increase morbidity mortality . This study provide continued access registry cardiac resynchronization therapy defibrillation ( CRT-D ) , help resynchronize ( coordinate ) rhythm heart help leave ventricle contract ( pump blood ) uniformly , patient severe heart failure ( NYHA Class III IV ) . Quality life , adverse event device success analyze report .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Accepted indication ICD implant Severe heart failure ( NYHA Class III IV ) time enrollment May preexisting ICD , provide subject stable , optimal medical regime Sinus rhythm spontaneous QRS duration great equal 150 m , QRS duration great equal 130 m interventricular mechanical delay ( IVMD ) great equal 40 m Leftventricular ejection fraction ( LVEF ) 35 % less Any generally accept indication standard cardiac pacing , contraindication standard cardiac pace Any contraindication ICD therapy Currently implant lead position coronary sinus Hypertrophic obstructive cardiomyopathy Acute myocarditis Unstable coronary symptom ( unstable angina myocardial infarction ) within last month Recent plan cardiac revascularization coronary angioplasty Correctable valvular disease primary cause heart failure Mechanical tricuspid valve Chronic atrial arrhythmia cardioversion atrial fibrillation within past month , paroxysmal atrial fibrillation require new pharmacologic therapy within past month Systolic blood pressure consistently 170 mmHg consistently 80 mmHg Supine rest heart rate exceed 100 bpm Receiving continuous IV infusion positive inotropic therapy intermittent therapy ( IV infusion ) twice per week Heart transplant recipient Primary pulmonary disease severity might limit patient 's ability perform treadmill test Serum creatinine 3.0 mg/dL Serum hepatic function three time upper normal limit Cerebrovascular event within previous three month Inability walk physical impediment might prevent patient complete maximum , symptomlimited treadmill test Age le 18 year Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>ICD</keyword>
	<keyword>Implantable Cardioverter-Defibrillator</keyword>
	<keyword>Defibrillator</keyword>
</DOC>